VIGIL NEUROSCIENCE INC's ticker is and the CUSIP is 92673K108. A total of 48 filers reported holding VIGIL NEUROSCIENCE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,285 | -42.7% | 1,908,135 | -0.2% | 0.44% | -20.8% |
| Q2 2023 | $17,965 | -18.2% | 1,911,191 | -14.8% | 0.56% | -57.3% |
| Q1 2023 | $21,962 | -21.7% | 2,243,352 | 0.0% | 1.30% | -16.6% |
| Q4 2022 | $28,042 | -99.9% | 2,243,352 | -1.8% | 1.56% | +76.2% |
| Q3 2022 | $20,799,000 | +618.9% | 2,285,574 | +103.9% | 0.89% | +472.9% |
| Q2 2022 | $2,893,000 | -63.3% | 1,121,191 | 0.0% | 0.16% | -53.0% |
| Q1 2022 | $7,882,000 | – | 1,121,191 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 4,214,498 | $22,716,144 | 65.40% |
| Atlas Venture Life Science Advisors, LLC | 5,836,874 | $31,460,750 | 4.87% |
| Trustees of Columbia University in the City of New York | 192,973 | $1,040,124 | 1.91% |
| Pivotal bioVenture Partners Investment Advisor LLC | 560,595 | $3,021,607 | 1.20% |
| Artal Group S.A. | 1,908,135 | $10,285 | 0.44% |
| Deep Track Capital, LP | 1,767,131 | $9,524,836 | 0.37% |
| DAFNA Capital Management LLC | 172,308 | $928,740 | 0.29% |
| BVF INC/IL | 1,813,633 | $9,775,482 | 0.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,827,400 | $9,849,686 | 0.22% |
| Cormorant Asset Management, LP | 616,786 | $3,324,477 | 0.19% |